Clinical trials sponsored by UCB Biopharma SRL
8
Recruiting trials
15
Conditions studied
Phase breakdown
Phase 1 2Phase 2 2Phase 3 3Not applicable 1
Conditions studied
Recruiting trials led by UCB Biopharma SRL
- A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic Dermatitis
- A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis
- A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
- A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis
- A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
- A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
- A Study to Test the Safety and Tolerability of Brivaracetam in Children and Adolescents With Seizures
- SLC6A1-NDD Prospective Longitudinal Natural History Study
Common questions
How many trials is UCB Biopharma SRL recruiting for?
UCB Biopharma SRL is the lead sponsor of 8 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.